Heart Test Laboratories (HSCS) Stock Forecast & Price Prediction

Estimation of the future price movement of Heart Test Laboratories stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $0.21

Concensus $3.00


Low $3.00

Median $3.00

High $3.00

Based on analysts projections #HSCS is expected to experience a positive growth trajectory over the next year.

The current average HSCS price target, as estimated by these analysts, is $3.00.

The predictions for the future HSCS stock price range from a low of $3.00 to a high of $3.00, highlighting the variability of market expectations for HSCS.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

HSCS stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Maxim Group December 19, 2022 Buy 3.00 0.90

Heart Test Laboratories (HSCS) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Heart Test Laboratories is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Sell

Financial Scores

Updated on: 27/11/2023

Altman Z-Score: -37.0

Piotroski Score: 2.0

ESG Score

Updated on: 27/11/2023

Environmental: 52.8

Social: 62.4

Governance: 60.9

Financial Health

Updated on: 27/11/2023

DCF: Strong Buy

ROE: Strong Buy

ROA: Strong Sell

Debt to equity ratio: Strong Sell

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Sell

HSCS Discounted Cash Flow

Updated on: 27/11/2023

$0.000
Discounted Cash Flow Value


$0.000
Current Price

HSCS Revenues by Segment

Updated on: 27/11/2023

No available data

Revenue from Contract with Customer, Excluding Assessed Tax

HSCS Revenues by Region

Updated on: 27/11/2023

No available data

HSCS Notes Due

Updated on: 27/11/2023

CIKExchangeTitle

There are no data to display

Heart Test Laboratories (HSCS) Social Sentiments

Monitoring bullish and bearish sentiments towards Heart Test Laboratories on Twitter and Stocktwits could help to forecast an upward or downward trend in Heart Test Laboratories stock price.

No social results for HSCS

Promising Stock Forecast for Heart Test Laboratories: Innovation and Growth in Medical Devices Sector

Heart Test Laboratories, with its stock ticker HSCS, is a leading player in the Medical Devices sector with a reputation for innovation and creativity. The company specializes in developing cutting-edge medical diagnostic equipment to improve patient care and reduce healthcare costs. Heart disease is the leading cause of death worldwide, and early detection is key to successful treatment. Heart Test... Read more

Promising Future: Stock Prediction for Heart Test Laboratories in the Booming Medical Devices Industry

The medical devices industry has always been a profitable sector in the stock market, with great growth potential and high demand. The industry comprises various companies that manufacture and distribute life-saving medical equipment used in hospitals and other healthcare facilities. One such company operating in the medical devices sector is Heart Test Laboratories, with a stock ticker named "Medical Devices."...
The company provides cutting-edge technology for cardiac management systems which include wireless 12-lead ECG machines, event recorders, Holter monitors, and pacemaker monitors. These products have gained widespread popularity owing to their accuracy, reliability and affordability.

Stock prediction experts have put out positive forecasts regarding the growth of the medical devices industry as advancements in technology continue to revolutionize healthcare. A recent report by Grand View Research estimated that the global medical device market will reach US$612 billion by 2025.

As it pertains to Heart Test Laboratories in particular, analysts expect robust revenue growth from the sale of their innovative ECG monitoring systems. With larger institutions recognizing the value of their technology within both hospitals and private practices alike.

Moreover, there are ongoing developments at Heart Test Laboratories (MedD) with new product launches scheduled for later this year along with expansion plans into additional markets across Europe. This further supports optimistic predictions about longer-term success while also suggesting short term exposure to fluctuations more aptly suited towards speculative allocations.

In summary, as per experts’ predictions within the stock market forecast discussions about Medical Devices sector suggest an upward climb trends following successful acquisitions and active product research & development by its key players like Heart Test Labortories (MedD). Though market forces can be unpredictable so investors are required to judiciously analyze risks involved before securing any position within this promising but volatile niche.">Read more